Scope Biosciences
Wageningen
About Scope Biosciences
Scope Biosciences is a company, specializing in the development of molecular diagnostics using CRISPR-Cas. It is a spin-off of Wageningen University & Research .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Funding stage: Seed
- Last round: Seed (Jun 2025)
- Website: scopebio.com
- Phone: [email protected]
Industries & Categories
AgTech, Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/scope-biosciences-109061 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.